WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients’ needs in biologics development and manufacture. The platform can significantly improve productivity and quality, and reduce cost-of-goods (COGS) in commercial manufacturing The platform’s unique design allows for outstanding adaptability for all common cell lines and diverse modalities WuXiUI™ showcases WuXi Biologics’ efforts to incorporate sustainable and innovative concepts in its CRDMO services

WUXI, China, Oct. 17, 2023 /PRNewswire/ — WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has launched a new proprietary bioprocessing platform WuXiUI™, an ultra-intensified, fed-batch solution that enhances the productivity and quality of multiple different CHO or other mammalian cell lines and product modalities.

To meet increasing demands for yield improvement, COGS reduction, and ESG consideration in the current bioprocess development, WuXi Biologics has developed WuXiUI™, offering flexible and cost-effective bioprocessing solutions for global clients. Compared with the conventional fed-batch bioprocesses, WuXiUI™ applies an innovative ultra-intensified intermittent-perfusion fed-batch (UI-IPFB) strategy in upstream production to realize a 3 to 6-fold increase in productivity in a typical culture duration of 14 days for a fed-batch process – for different molecule modalities such as mAbs, bispecifics and recombinant proteins – while ensuring desirable product quality. For example, by leveraging WuXiUI™, the titer of a bispecific antibody achieved 25 g/L in 14 days – 5 times higher than the same-scale traditional fed-batch process – with expected product quality.

WuXiUI™ reduces drug substance manufacturing COGS by an estimated 60-80% compared to traditional fed-batch processes in single-use bioreactors, enhancing the competitiveness of commercial products. The platform is also easily adopted and can be scaled up/out in existing facilities without additional requirements for major equipment or complex operations, bringing minimum changes to the downstream process. Adhering to WuXi Biologics’ ESG strategy, WuXiUI™ has a lower carbon footprint than traditional or other intensified fed-batch processes due to more efficient media consumption and reduced waste generation.

Dr. Chris Chen, CEO of WuXi Biologics, commented, "We are pleased to launch the WuXiUI™ platform to provide diverse bioprocessing solutions for global clients that enhance productivity and product quality, and tremendously reduce product COGs. WuXi Biologics’ continual launch of new technology platforms comes from our drive to push boundaries and foster innovation – all with the goal of enabling our global partners to bring more high-quality and affordable biologics to patients worldwide."

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2023, WuXi Biologics is supporting 621 integrated client projects, including 22 in commercial manufacturing.

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

Contacts

Business
[email protected]

Media
[email protected]

Source : WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING and BURLINGTON, Mass., Oct. 17, 2023 /PRNewswire/ — CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation in China,  committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced today that the National Medical Products Administration of China (NMPA) has accepted the New Drug Application (NDA) for CAN108 (Maralixibat Chloride Oral Solution /迈芮倍®/LIVMARLI®) for the treatment of cholestatic pruritus in patients two months of age and older with progressive familial intrahepatic cholestasis (PFIC). PFIC is a rare genetic disorder that causes progressive liver disease typically leading to liver failure. PFIC has been included in the "First National List of Rare Diseases" in China since May 2018. The application has been granted priority review.

The submission is based on data from the MARCH PFIC Phase 3 study of LIVMARLI. MARCH PFIC is the largest randomized trial conducted in PFIC, with 93 patients across a range of genetic PFIC subtypes, including PFIC1, PFIC2, PFIC3, PFIC4, PFIC6 and unidentified mutational status. In the study, LIVMARLI-treated patients had statistically significant improvements in pruritus (p< 0.0001), serum bile acids (p<0.0001), bilirubin (p=0.0471), and growth as measured by weight z-score (p=0.0391), in the cohort evaluating combined genetic subtypes.

LIVMARLI is the first approved drug to treat cholestatic pruritus associated with Alagille syndrome in the US, Canada, Europe and China. 

CANbridge and Mirum Pharmaceuticals, Inc. (Mirum) signed an exclusive license agreement for the development, manufacturing and commercialization of LIVMARLI in Greater China in 2021. Mirum has also submitted a supplemental NDA to the U.S. Food and Drug Administration (FDA) for the treatment of cholestatic pruritus in patients three months of age and older with PFIC, as well as a marketing authorization variation to the European Medicines Agency (EMA) for the treatment of PFIC. Under the terms of the agreement, CANbridge has the right to develop manufacture and commercialize LIVMARLI for three indications: Alagille syndrome (ALGS), PFIC and biliary atresia (BA), along with select other indications, in Greater China. LIVMARLI is currently being evaluated in an ongoing Global Phase 2 study in China known as EMBARK for the treatment of BA.

"The acceptance of the NDA for LIVMARLI in PFIC by the NMPA is another step towards our goal of bringing treatments to patients in China who suffer from rare diseases," said James Xue, Ph.D., CANbridge Founder, Chairman and CEO. "With the approval of Livmarli for the treatment of patients with ALGS in mainland China, Hong Kong and Taiwan already received earlier this year, PFIC represents the opportunity for CANbridge to expand the label and maximize the potential of this product.  We eagerly anticipate the formal approval of this indication in China, where it holds the potential to provide much-needed relief to patients and their families."

About PFIC

Progressive familial intrahepatic cholestasis (PFIC) is a rare genetic disorder that causes progressive liver disease typically leading to liver failure. In people with PFIC, liver cells are less able to secrete bile. The resulting buildup of bile causes liver disease in affected individuals. Signs and symptoms of PFIC typically begin in infancy. Patients experience severe itching, jaundice, failure to grow at the expected rate (failure to thrive), and an increasing inability of the liver to function (liver failure). The disease is estimated to affect one in every 50,000 to 100,000 births in the United States and Europe.  Six types of PFIC have been genetically identified, all of which are similarly characterized by impaired bile flow and progressive liver disease.

About LIVMARLI

LIVMARLI® (maralixibat) oral solution is a minimally absorbed ileal bile acid transporter (IBAT) inhibitor that blocks the enterohepatic circulation of bile acids, reduces bile acid levels in the liver and serum, reduces the resultant liver injury and relieves pruritus. LIVMARLI is the first approved drug to treat cholestatic pruritus associated with Alagille syndrome in the US, Canada, Europe and China. 

LIVMARLI is currently being evaluated in late-stage clinical studies in other rare cholestatic liver diseases including biliary atresia.  LIVMARLI has been granted Breakthrough Therapy designation for ALGS and PFIC type 2 and orphan designation for ALGS, PFIC and biliary atresia by the FDA.

IMPORTANT SAFETY INFORMATION

LIVMARLI can cause side effects, including:  

Changes in liver tests. Changes in certain liver tests are common in patients with Alagille syndrome and can worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your healthcare provider should do blood tests before starting and during treatment to check your liver function. Tell your healthcare provider right away if you get any signs or symptoms of liver problems, including nausea or vomiting, skin or the white part of the eye turns yellow, dark or brown urine, pain on the right side of the stomach (abdomen) or loss of appetite.   

Stomach and intestinal (gastrointestinal) problems.  LIVMARLI can cause stomach and intestinal problems, including diarrhea, stomach pain, and vomiting during treatment. Tell your healthcare provider right away if you have any of these symptoms more often or more severely than normal for you.  

A condition called Fat Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamin A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your healthcare provider should do blood tests before starting and during treatment.   

Other common side effects reported during treatment were gastrointestinal bleeding and bone fractures. 

About CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc. (HKEX:1228) is a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies for rare disease and rare oncology. CANbridge has a differentiated drug portfolio, with four approved drugs and a pipeline of 10 assets, targeting prevalent rare disease and rare oncology indications that have unmet needs and significant market potential. These include Hunter syndrome and other lysosomal storage disorders, complement-mediated disorders, hemophilia A, metabolic disorders, rare cholestatic liver diseases and neuromuscular diseases, as well as glioblastoma multiforme. The CANbridge Next-Generation Innovation and Process Development Facility is developing novel, potentially curative, gene therapies for rare genetic diseases, including Pompe disease, Fabry disease, spinal muscular atrophy (SMA) and other neuromuscular conditions, and collaborates with world-leading researchers and biotech companies.

For more on CANbridge Pharmaceuticals Inc., please go to: www.canbridgepharma.com.

Forward-Looking Statements

The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the data on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development.

Source : CANbridge Announces NDA Acceptance of CAN108 (邁芮倍®/LIVMARLI®) for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis (PFIC) by China's National Medical Products Administration

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

All companies, regardless of size or industry, are vulnerable to cyber threats like phishing scams, ransomware attacks, and data breaches, according to Prism Global Group. 

LONDON, Oct. 17, 2023 /PRNewswire/ — In today’s digital age, the threat of cybercrime looms large over businesses and individuals alike. The need for robust cybersecurity solutions has never been more critical as the world becomes increasingly interconnected. To stay ahead of the curve, organisations must take proactive steps to protect their digital assets from malicious attacks.

Most companies that investors are looking at are proactive and vigilant in addressing cybersecurity threats. Cybersecurity must be prioritised, as it serves as an intelligent investment, safeguarding the firm’s assets and reputation and ensuring long-term success.

Alev Dover, CEO of Prism Global Group, stated: "Cybersecurity is a significant concern for businesses of all sizes and industries. Threats like data breaches, ransomware, and scams can lead to financial losses, reputation damage, and legal responsibility. Protecting your business against these threats is crucial.

Prism has identified five effective strategies to enhance cybersecurity. When investors look at the company that they wish to invest in, these controls are a helpful list to check against:

1. Is the firm regularly testing their defences and ensuring they are prepared for any possible situation?

As technology advances, the potential for security breaches increases. With each new addition to a company’s systems, such as users, applications, devices, and acquisitions, the complexity of cybersecurity grows. Therefore, organisations need a regular process that identifies security gaps, vulnerabilities, and loopholes before they lead to major incidents.

2. How is the firm implementing identity and access management systems?

To keep daily operations running smoothly and protect sensitive information from unauthorised access, it’s crucial to have a system that allows for appropriate data access to prevent internal breaches. Data breaches are caused by insider threats like misusing privileged access, weak or stolen passwords, unpatched applications, malware, social engineering, and physical attacks. To protect against both external and internal threats, it’s crucial that the firm has a robust data security program in place to safeguard sensitive data.

3. Does the firm conduct regular cybersecurity awareness training?

Equipping employees with cybersecurity knowledge and best practices is essential to defend against phishing and social engineering attacks. Providing education on identifying these types of attacks and understanding what information should not be shared is crucial. Every individual within an organisation can play a significant role in maintaining cybersecurity.

4. What Network Monitoring measures are in place?

Effective network security monitoring services safeguard organisations against potential security threats. By providing constant surveillance, these services enable prompt identification and response to suspicious activities, thus minimising the risk of a significant breach. To ensure maximum protection, it is crucial to have trained professionals monitoring the business network for any unusual behaviour that may indicate a potential attack.

5. Who at the firm is responsible for device discovery & continuous policy enforcement?

To improve network security, teams can identify and evaluate endpoints for vulnerabilities. If any issues are found, steps can be taken to address them, such as separating insecure endpoints from the rest of the network, and the problem can be quickly discovered and fixed if a resource violates established security policies. Newly installed devices that match a particular device profile with an active policy are also automatically protected.

Dover concluded: ‘From reading industry research and talking with our investment networks we can conclude that significant cybersecurity breaches cause material, short term declines in stock price and market share. These analyses are based on reviewing publicly disclosed breaches and tracking stock price post-breach.

Our company’s equity investment platform and products are highly secure in terms of cybersecurity. This assurance enables us to instil confidence for all our clients and the financial markets when they make long-term investment decisions. We maintain strict controls that undergo regular reviews to ensure the utmost security.

About Prism Global Group

Prism Global Group is an innovator of a new equity orientated financial infrastructure.

The company was established in Sydney and has expanded its international footprint under CEO Alev Dover.  PRISM moved its global HQ to London in 2022.

This disclaimer is for Prism Global Group Plc (Reg No: 14476793), Prism Global Group Ltd (ACN 630 730 415), Prism Global (UKEUR) Ltd (Reg No 13579812), Prism Operations Australia Pty Ltd (ACN650 476 378) and Prism Securities Australia Ltd (ACN 650 488 136) and any other associated entities referred to collectively as ‘Prism’.

Prism Operations Australia Pty Ltd is a Corporate Authorised Representative (authorised representative number: 1292289) of Sanlam Private Wealth Pty Ltd ("Sanlam") which is the holder of an Australian Financial Services Licence (AFS Licence No. 337927).

Prism Global (UKEUR) Ltd (FRN: 999737) is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority (FRN: 550103) as an arranger for investments only. For avoidance of doubt, Prism Global (UKEUR) Limited does not manufacture or issue investments, and only arranges for deals in investments issued by Prism Group companies.

Source : Top 5 questions to cover on cybercrime when looking at equity investing

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

ORLANDO, Fla., Oct. 17, 2023 /PRNewswire/ — Deltek, the leading global provider of software and solutions for project-based businesses, today announced the winners of its annual Most Valuable Project (MVP) Awards at Deltek ProjectCon 2023, the company’s yearly user conference. With the MVP Awards, Deltek honors the most innovative among its worldwide customers and partners across nine categories:

The Marketing Agency Award recognizes an advertising or digital marketing agency using Deltek solutions to power their creative business. This year’s winner, George P. Johnson, a Project Worldwide Agency, is the world’s leading experiential marketing agency. The agency successfully implemented Deltek WorkBook in the UK, Germany, and Dubai to achieve global expansion and collaboration among its offices. With the help of Deltek and implementation partner Tangram, the agency overcame complex government tax and multi-currency reporting challenges, and increased visibility into resource management, utilization rates and job lifecycle workflows for the 1,400 employees who use WorkBook daily.   

The Consulting Award recognizes a firm that is using Deltek as a key technology to deliver successful engagements to their clients. This year’s winner, Boulay, is an accounting, audit, tax and financial consulting firm headquartered in Minneapolis. Boulay decided to upgrade its Deltek Maconomy ERP system to Maconomy in the Cloud to align with its business goals of growth, productivity and security in a cloud environment.  After the migration, Boulay saw a 50% reduction in the time needed to upgrade to Maconomy in the Cloud, expediting its timeline, streamlining user communication and allowing the company to add additional contractors to support growth.    

The Construction Award recognizes a firm in the construction industry that is utilizing Deltek to successfully execute projects. This year’s winner, Pyro-Comm Systems, Inc., a premier fire alarm and life safety contractor, has used Deltek ComputerEase as its financial backbone for over ten years.  Pyro-Comm successfully increased control of project financial performance, including consolidating two ComputerEase systems into one by leveraging Deltek’s payroll services in just two weeks. Through customized reporting and application utilization, Pyro-Comm can now provide executive management insight and confidence across its financial reporting. 

The Professional Services Award recognizes a firm doing innovative work and succeeding with the help of Deltek solutions. This year’s winner, Englobe is a mid-market engineering and environmental services firm, with more than 3,000 employees and a well-established network of offices and facilities across Canada. Englobe uses Deltek Vantagepoint as the foundation of its daily operations across 23,000 projects annually, relying on it to help streamline financials, optimize project management, and deliver high-quality solutions to its clients. Leveraging Deltek Vantagepoint has led to improved resource utilization, efficient project management and an overall increase in profitability for Englobe.   

The Partner Award recognizes a Deltek partner and customer that together have completed an exceptional implementation of a Deltek solution. This year’s winners, Deltek Premier Partner Rhodium Digital and customer Wade Consulting, are both based in Alberta, Canada. With recent rapid growth, Wade needed a powerful and integrated ERP system to manage their entire product lifecycle and gain deeper insights into individual project health. With Rhodium Digital’s expertise as a Deltek Vantagepoint partner, Wade Consulting was able to move off QuickBooks® and time-consuming manual spreadsheet processes and go live in just two months, laying the foundation for double-digit growth for years to come. 

The Small to Midsize Business Award recognizes a growing business doing innovative work and succeeding with the help of Deltek solutions. This year’s winner, Connexus Corporation, is a women-owned, Virginia-based global consulting firm that designs sustainable strategies to link developing economies with global markets that enhance the lives of the poor. Connexus implemented Deltek Costpoint to handle the complex needs of managing international development projects while maintaining its prime contractor status on the Feed the Future Senegal Nafoore Warsaaji Activity, funded through the Feed the Future initiative coordinated by the United States Agency for International Development (USAID). With Costpoint, Connexus was able to streamline project management, accounting, and reporting processes, and ensure compliance with USAID regulations. Connexus also gained real-time visibility into project performance and financial status, enabling it to make informed decisions and optimize their resources. 

The Enterprise Award recognizes a large business that leverages Deltek solutions to achieve its global mission. This year’s winner, Fluor’s Mission Solutions Business Group, the government contracting division of the FORTUNE 500 company, provides nuclear engineering and facility operation services, construction management, rapid response logistics, global military base operations and maintenance, as well as humanitarian and disaster relief support.  Mission Solutions moved its entire ERP system from SAP, and now leverages several of Deltek’s industry-specific solutions, including Deltek Costpoint, Talent Management, Cobra, Acumen and GovWin IQ to power its project lifecycle. Mission Solutions migrated 1,900 employees to Deltek Costpoint in just ten months, saving six million dollars in operational expenses while remaining fully compliant with government regulations.

The Architecture and Engineering (A&E) Award recognizes an A&E firm that is utilizing Deltek to successfully execute projects. This year’s winner, DeSimone Consulting Engineering, provides high-quality structural engineering, façade consulting, construction consulting, forensics services (litigation support), integrated design, detailing services, and protective design for all types of buildings. The high-growth, 600-employee firm upgraded from Deltek Vision to Vantagepoint in 2023 while consolidating disparate financial systems and integrating client relationship management, corporate risk, and project data following multiple acquisitions. With Vantagepoint, DeSimone grew its revenue by 33%, increased invoice efficiency, and saved hundreds of thousands of dollars in overhead costs by streamlining platforms to one integrated ERP system.  

The Government Contracting Award recognizes a firm that is using Deltek to successfully execute business with federal, state or local governments. This year’s winner, UIC Government Services and The Bowhead Family of Companies, provides various services for defense and civilian government agencies. UIC Government Services leverages Deltek Costpoint, GovWin IQ, PPM Solutions, and TIPQA to run a complex accounting and corporate structure for over 36 subsidiaries and more than 3,000 employees. UIC Government Services’ decade-long history with Deltek’s government-compliant solutions has decreased its operating support costs year over year, with more than 35% of invoices now processed by software, while also increasing project efficiencies.  

"I am thrilled to celebrate the winners of this year’s MVP Awards and all the great work done by each business. We are honored that they have each chosen Deltek’s industry-leading solutions as a key part of their path toward success," said Brian Daniell, Deltek’s Chief Customer Officer. "This year we received nominations from all over the globe, from companies of all sizes, and with a huge range of business goals they were able to achieve over the past year. On behalf of everyone at Deltek, we’re delighted to congratulate this outstanding group of winners!"

Learn how Deltek customers are powering project success.

About Deltek

Better software means better projects. Deltek is the leading global provider of enterprise software and information solutions for project-based businesses. More than 30,000 organizations and millions of users in over 80 countries around the world rely on Deltek for superior levels of project intelligence, management and collaboration. Our industry-focused expertise powers project success by helping firms achieve performance that maximizes productivity and revenue. Learn more at www.deltek.com.

Deltek Contact
Deltek Media Relations Team
[email protected]

Source : Deltek Celebrates the 16th Annual MVP Award Winners at Deltek ProjectCon 2023

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Oct. 17, 2023 /PRNewswire/ — WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider committed to offering technical support and digital transformation tools for enterprises across various industries, today announced the integration and enhancement of its two business segments in China: Yuetao APP and Haolin Haowu APP. The unified platform will now be known as Yuetao Haowu APP.

Yuetao Haowu APP is a high-quality discount shopping platform for the Consumer-end (the "C-end"), which allows consumers to achieve a new model of saving money and making money through membership. Additionally, consumers can earn points during shopping and redeem them for a wide variety of products.

The upgrade of WeTrade’s China business sector is an important step for WeTrade, especially following the recent change of its management team. The focus is to drive the Company’s performance growth through the development of C-end business.

Mr. Zheng Dai, founder and Chairman of the Board of the Company, comments:"WeTrade is an enterprise that focuses on the development of the consumer sector and has achieved industry leadership in the micro business industry. In recent years, we have accumulated huge advantages in user operation and product marketing. Recognizing the evolving needs of C-end users and their consumption habits, we hope to further optimize C-end business, achieve parallel development of domestic and international businesses, and create greater value for shareholders."

About WeTrade Group Inc.
WeTrade Group Inc. is a global diversified "Software as a Service" ("SaaS") technology service provider committed to offering technical support and digital transformation tools for enterprises across various industries. WeTrade Group consists of four business segments: YCloud, WTPay, Y-Health, and YG.

YCloud is a micro-business cloud intelligent system launched by WeTrade, serving the global micro-business industry. YCloud strengthens users’ marketing relationships and CPS commission profit management through leading technology and big data analysis. It also helps increase payment scenarios to boost customers’ revenue through multi-channel data statistics, AI fission, and management, as well as an improved supply chain system.

Independently developed by the Company, WTPay supports multiple methods of online payment and eight mainstream digital wallets in over 100 countries, helping customers quickly realize global collection and payment business.

Y-Health is the sector focusing on public health business, engaging in the development of global business for biological health and medical enterprises. Currently, Y-Health mainly focuses on epidemic detection and prevention, daily healthcare, traditional Chinese medicines, and more.

YG is the new energy business segment that mainly provides tools and technical support for the digital new energy industry in the Middle East and Central Asia.

For more information, please visit https://ir.wetg.group.

Forward-Looking Statements

This press release contains information about the Company’s view of its future expectations, plans, and prospects, constituting forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements due to various factors, including but not limited to, risks and uncertainties associated with its ability to raise additional funding, maintain and grow its business, variability of operating results, enhance its brand, develop and introduce new products and services, successfully integrate acquired companies, technologies, and assets into its portfolio of products and services, conduct marketing and other business development initiatives, face competition in the industry, navigate general government regulation, economic conditions, dependence on key personnel, attract, hire and retain personnel with the technical skills and experience necessary to meet clients’ requirements, and protect its intellectual property. The Company encourages you to review other factors that may affect its future results in the Company’s annual reports and in its other filings with the Securities and Exchange Commission.

Source : WeTrade Group Inc. Upgrades its China Business to Drive Multi-Faceted Growth

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SYDNEY, Oct. 17, 2023 /PRNewswire/ — V2 Digital, a transformation consultancy firm, has recently been recognised as one of the best places to work in Australia for 2023. During the assessment, V2 Digital achieved outstanding results in a number of areas, and remains committed to using the feedback to continue fostering a culture where all employees can meaningfully contribute and reach their potential.

To achieve recognition through the Best Places to Work Program, V2 Digital was assessed by surveying employees about topics including leadership, HR practices, compensation, benefits, culture and career development opportunities.

Best Places to Work is an international certification program, considered as the ‘Platinum Standard’ in identifying and recognising top workplaces around the world, providing employers the opportunity to learn more about the engagement and the satisfaction of their employees and honor those who deliver an outstanding work experience with the highest standards in regards to working conditions.

In a statement from Craig Howe, CEO of V2 Digital "We’re immensely proud of our Best Places to Work certification, which reflects V2 Digital’s commitment to delivering a positive employee experience. By embedding a supportive leadership team, providing career growth opportunities, fostering collaboration and teamwork and giving back, we’re continually creating a thriving workplace built on trust. At our core is a focus on continuous improvement, which we call #VersionUp. It is a culture of learning and empowerment, making a positive impact on our clients, our people, and our communities. It’s wonderful to already be recognised as one of the Best Places to Work in Australia, and it’s only the beginning for V2!"

For more information, please visit www.bestplacestoworkfor.org

Source : V2 Digital earns the Best Place to Work certification for 2023

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Oct. 16, 2023 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed multi-modal EEG-based hybrid BCI system with visual servo module which combines SSVEP and motor image signals and introduces a visual servo module to improve the robot’s performance in performing grasping tasks. By combining different types of EEG signals, users can control the robot more freely and intuitively to perform diverse actions, thus providing a more satisfying service experience.

The approach of the multi-modal EEG-based hybrid BCI system with visual servo module mainly involves the design of signal acquisition, signal processing, control command generation and visual servo module.

1. Signal Acquisition: The system first needs to acquire the user’s EEG signal and visual feedback signal. In order to realize multi-modal control, the system acquires both SSVEP and motor image signals.

SSVEP Signal Acquisition: By placing EEG electrodes on the user’s scalp, the system can acquire the user’s SSVEP signals. SSVEP is a type of flicker visual evoked potential, in which the brain generates electrical signals of a specific frequency when the user’s visual attention is focused on a specific frequency of flicker stimuli. In order to realize multi-modal control, the system provides three different frequencies of flicker stimuli on the visual interface, and each stimulus corresponds to one control command of the robot, such as forward, turn left, and turn right.

Motor Image Signal Acquisition: In addition to the SSVEP signal, the system needs to acquire the motor image signal of the user. This is achieved by acquiring the user’s motor image signals through EEG electrodes over a specific area. When the user imagines a grasping movement, the associated motor image signals are captured and used to control the robot to perform the grasping action.

Signal Processing: After signal acquisition, the raw EEG signals obtained need to be processed and analyzed in order to extract useful information and to perform feature extraction and classification to recognize the user’s intention.

SSVEP signal processing: For SSVEP signals, the system first needs to filter and pre-process the original signal to eliminate noise and interference. Then, by extracting spectral features, it recognizes which frequency the user’s current visual attention is focused on, so as to determine whether the user’s intention is to turn forward, left or right.

Motor Image Signal Processing: For motor image signals, the system needs to pre-process the raw signals to eliminate noise and interference. Then, the user’s imagined actions, such as grasping motion, are recognized through feature extraction and classification.

In WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module, the generation of control commands is the core part of the whole system. Control command generation involves parsing the recognized EEG signals and mapping them to the corresponding robot actions.

3. Control Command Generation: After recognizing the user’s intention, the system generates corresponding control commands according to the results obtained, so as to control the robot’s actions.

SSVEP control command generation: For SSVEP signals, the system uses spectrum analysis to process the signals. Spectral analysis extracts which frequency the user’s current visual attention is focused on. Different flashing stimuli provided on the visual interface correspond to different movements of the robot, such as forward, left turn and right turn. By recognizing the frequency at which the user’s visual attention is located, the system is able to determine the user’s intention and generate corresponding control commands accordingly.

Motor Image Control Command Generation: For motor image signals, the system utilizes feature extraction and classification techniques to recognize the user’s imagined movements. When the user imagines a grasping motion, specific motor image signals are captured. The system recognizes these features by training machine learning algorithms and generates corresponding control commands based on the recognition results to instruct the robot to perform the grasping motion.

4. Visual servo module design: The visual servo module is designed to improve the performance and accuracy of the robot in performing the grasping task. This module can adjust the robot’s grasping attitude and strength in real time, making the grasping action more accurate and reliable. The visual servo module captures the real-time visual feedback from the robot performing the grasping task through the camera and combines it with the user’s motor image signal for dynamic adjustment.

Visual Feedback Acquisition: The camera captures real-time visual feedback from the robot as it performs a grasping task. This feedback may include the position of the robot’s end-effector (e.g., a mechanical gripper), its attitude, the position and shape of the target object, and so on.

Feature extraction: Extracting useful features from the visual feedback. These features may include information such as edges, colors, and shapes of the target object, as well as position and attitude information of the robot’s end-effector.

Control Command Adjustment: The features extracted from the visual feedback are combined with the user’s motor image signals to make dynamic adjustments. For example, if the user imagines grasping a more distant object, the system can adjust the robot’s grasping posture and strength accordingly, enabling the robot to better accomplish the grasping task.

Feedback control: The vision servo module monitors the robot’s progress in performing the grasping task in real time and provides feedback control according to the actual execution. If there is any error or instability in the grasping process, the system can make timely adjustments so that the robot can complete the grasping action more accurately.

With the visual servo module, WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module can more flexibly adapt to different grasping scenarios and user intentions, providing a higher quality service experience. The introduction of this module enhances the autonomy and adaptability of the robot to perform grasping tasks, enabling the system to realize more complex and natural multi-modal control.

Traditional brain-computer interface systems usually provide only a limited number of control commands, restricting the way the user interacts with the robot. WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module combines different types of EEG signals to enable richer and more varied control commands, allowing users to visualize different actions or focus on different frequencies of stimuli to achieve more complex robot control, thus providing a more flexible and natural interaction experience. The user can visualize different movements or focus on different frequencies of stimuli to achieve more sophisticated robot control, thus providing a more flexible and natural interaction experience.

WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module By combining multiple EEG signals, the system is able to recognize the user’s intention more accurately. For example, the combination of SSVEP signals and motor image signals enables higher control accuracy, while the introduction of the visual servo module enables real-time adjustments to the robot’s execution movements and improves the reliability and accuracy of the control commands, resulting in a robot that better responds to the user’s commands. The system is not only limited to robot control, but can also be applied to other fields, such as virtual reality, rehabilitation therapy, and control of assistive devices. The expansion of this technology provides new possibilities for the application scope of brain-computer interface technology and promotes the development of the human-computer interaction field.

WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module involves the combination and application of multiple technologies, such as EEG signal processing, feature extraction, machine learning algorithms, and visual servo technology. Addressing the coordination and integration of these technologies, it promotes the further development of BCI technology and lays the foundation for higher-level brain-computer interface applications.WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module provides richer and more diversified control commands, improves control accuracy and reliability, and expands the brain-computer interface applications. WiMi’s multi-modal EEG-based hybrid BCI system with visual servo module provides richer and more diversified control commands, improves control precision and reliability, expands the application fields of brain-computer interfaces, and improves the user experience and quality of life, as well as pushes forward the development and innovation of BCI technology, which is expected to play an important role in the field of intelligent robotics and human-computer interaction in the future.

About WIMI Hologram Cloud

WIMI Hologram Cloud, Inc. (NASDAQ:WIMI) is a holographic cloud comprehensive technical solution provider that focuses on professional areas including holographic AR automotive HUD software, 3D holographic pulse LiDAR, head-mounted light field holographic equipment, holographic semiconductor, holographic cloud software, holographic car navigation and others. Its services and holographic AR technologies include holographic AR automotive application, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, interactive holographic communication and other holographic AR technologies.

Safe Harbor Statements

This press release contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Among other things, the business outlook and quotations from management in this press release and the Company’s strategic and operational plans contain forward−looking statements. The Company may also make written or oral forward−looking statements in its periodic reports to the US Securities and Exchange Commission ("SEC") on Forms 20−F and 6−K, in its annual report to shareholders, in press releases, and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. Several factors could cause actual results to differ materially from those contained in any forward−looking statement, including but not limited to the following: the Company’s goals and strategies; the Company’s future business development, financial condition, and results of operations; the expected growth of the AR holographic industry; and the Company’s expectations regarding demand for and market acceptance of its products and services.

Further information regarding these and other risks is included in the Company’s annual report on Form 20-F and the current report on Form 6-K and other documents filed with the SEC. All information provided in this press release is as of the date of this press release. The Company does not undertake any obligation to update any forward-looking statement except as required under applicable laws.

Source : WiMi Developed Multi-modal EEG-Based Hybrid BCI System with Visual Servo Module

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network